Live feed08:00:00·287dPRReleasePelthos Therapeutics Launches ZELSUVMI™ (berdazimer) Topical Gel 10.3%, the First and Only FDA-Approved At-Home Treatment for Molluscum ContagiosumCHRO· Channel Therapeutics CorporationPTHS· Pelthos Therapeutics Inc.Health CareOriginal source
